North Dakota 2025-2026 Regular Session

North Dakota Senate Bill SB2248 Latest Draft

Bill / Introduced Version Filed 01/20/2025

                            25.0547.02000
Sixty-ninth
Legislative Assembly
of North Dakota
Introduced by
Senators Barta, Dever, Lee
Representatives D. Ruby, Weisz, Louser
A BILL for an Act to amend and reenact section 19-02.1-16.3 of the North Dakota Century 
Code, relating to step therapy protocols; to provide for a report to the legislative assembly; to 
provide for application; and to provide an expiration date.
BE IT ENACTED BY THE LEGISLATIVE ASSEMBLY OF NORTH DAKOTA:
SECTION 1. AMENDMENT. Section 19-02.1-16.3 of the North Dakota Century Code is 
amended and reenacted as follows:
19-02.1-16.3. Pharmacy benefits managers - Step therapy protocols - Limitations.
1.As used in this section:
a."Associated condition" means a symptom or side effect associated with 
metastatic cancer or its treatment and which, in the judgment of the health care 
practitioner, further jeopardizes the health of an individual if left untreated.
b."Metastatic cancer" means cancer that has spread from the primary or original 
site to lymph nodes, nearby tissues, or other parts of the body.
b.c."Pharmacy benefits manager" has the same meaning as in section 19-03.6-01.
c.d."Step therapy protocol" means a protocol requiring an individual use a drug, or 
sequence of drugs, other than the prescription drug, or sequence of prescription 
drugs, the individual's health care provider recommends for the individual's 
treatment, before the pharmacy benefits manager or health plan allows coverage 
for the recommended prescription drug, or sequence of prescription drugs.
2.A pharmacy benefits manager or a health plan may not require a step therapy protocol 
for coverage of a recommended prescription drug, or sequence of prescription drugs, 
approved by the United States food and drug administration if:
Page No. 1	25.0547.02000
 SENATE BILL NO. 2248
    
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22 Sixty-ninth
Legislative Assembly
a.The recommended prescription drug, or sequence of prescription drugs, is 
prescribed to treat the individual's diagnosis of metastatic cancer or an 
associated condition; and
b.The use of the recommended prescription drug, or sequence of prescription 
drugs, is consistent with the United States food and drug administration-approved 
indications or is supported by peer-reviewed medical literature.
3.This section does not require coverage of a nonformulary prescription drug.
SECTION 2. PUBLIC EMPLOYEES RETIREMENT SYSTEM - STEP THERAPY 
PROTOCOLS FOR ASSOCIATED CONDITIONS OF METASTATIC CANCER - REPORT TO 
LEGISLATIVE ASSEMBLY. Pursuant to section 54-03-28, the public employees retirement 
system shall prepare and submit for introduction a bill to the seventieth legislative assembly to 
repeal the expiration date for this Act and to extend step therapy protocols for associated 
conditions of metastatic cancer to all group and individual health insurance policies. The public 
employees retirement system shall append a report to the bill regarding the effect of the step 
therapy protocols for associated conditions of metastatic cancer on the system's health 
insurance programs, information on the utilization and costs relating to the coverage, and a 
recommendation regarding whether the coverage should be continued.
SECTION 3. APPLICATION. This Act applies to health insurance benefits coverage 
provided by the uniform group insurance program under chapter 54-52.1 which begins after 
June 30, 2025, and which does not extend past June 30, 2027.
SECTION 4. EXPIRATION DATE. This Act is effective through June 30, 2027, and after that 
date is ineffective.
Page No. 2	25.0547.02000
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22